A revolutionary mRNA cancer vaccine developed by Moderna and Merck, combined with immunotherapy, shows a 42% reduction in ...

Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...

Novartis presents disappointing data for remibrutinib, its oral multiple sclerosis drug, showing lower than anticipated ...

AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...

The deal follows positive mid-stage results for Gilead's experimental pill for chronic bowel disease, emvistegrast, on Monday ...

The Indian government has established a three-member committee to review and overhaul regulations governing pharmaceutical ...

Telitacicept met the study's main goal and largely preserved kidney function over two years, while patients on placebo saw a ...

Moderna's stock plummeted over 25% after revealing late-stage trial results for its personalized melanoma vaccine, wiping $24 ...

CSL, Australia's leading biotechnology company, has appointed Deborah Waterhouse as its new CEO, marking a significant ...

The UK's MHRA has revoked the marketing approval for Valneva's chikungunya vaccine, Ixchiq, due to unfavorable benefit-risk ...

Explore how cheap Chinese antibiotics threaten the survival of Europe's final major penicillin manufacturing facility in ...

Alkem Laboratories embarks on a forensic audit to investigate alleged fund misappropriation by a former employee, appointing ...